Chemoinformaics analysis of 3-HEPTYL-PYRIDINE
| Molecular Weight | 177.291 | nRot | 6 |
| Heavy Atom Molecular Weight | 158.139 | nRig | 6 |
| Exact Molecular Weight | 177.152 | nRing | 1 |
| Solubility: LogS | -2.778 | nHRing | 1 |
| Solubility: LogP | 4.219 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 33.8091 |
| nHD | 0 | BPOL | 20.2009 |
| QED | 0.605 |
| Synth | 1.62 |
| Natural Product Likeliness | -0.311 |
| NR-PPAR-gamma | 0.025 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.003 |
| HIA | 0.002 |
| CACO-2 | -4.325 |
| MDCK | 0.0000206 |
| BBB | 0.984 |
| PPB | 0.906316 |
| VDSS | 1.735 |
| FU | 0.0686925 |
| CYP1A2-inh | 0.983 |
| CYP1A2-sub | 0.525 |
| CYP2c19-inh | 0.943 |
| CYP2c19-sub | 0.414 |
| CYP2c9-inh | 0.848 |
| CYP2c9-sub | 0.841 |
| CYP2d6-inh | 0.499 |
| CYP2d6-sub | 0.154 |
| CYP3a4-inh | 0.888 |
| CYP3a4-sub | 0.304 |
| CL | 9.271 |
| T12 | 0.598 |
| hERG | 0.109 |
| Ames | 0.007 |
| ROA | 0.272 |
| SkinSen | 0.946 |
| Carcinogencity | 0.113 |
| EI | 0.987 |
| Respiratory | 0.823 |
| NR-Aromatase | 0.931 |
| Antiviral | No |
| Prediction | 0.665816 |